Visual first β compact captions and precise citations below each figure. All claims are drawn only from the listed publications; each data point is cited.
Notes: the HNSCC single-cell spatial study reported a very large total of unique TCRΞ² CDR3 sequences across samples (raw unique sequences aggregated across patients); TCRMatch used curated IEDB-derived sets; TCR2HLA reports cohort scale (individuals) used to train classifiers; TCRanalyzer sample count reflects number of sequenced samples in that methods paper.
These medians come from the systematic assessment of bulk TCR-Seq methodological choices; the authors reported median clonotype counts for TRA and TRB across their RNA-based libraries.
Context: TCR-L reports median unique TCR sequences per TCGA SKCM patient derived from RNA-seq; Platypus example datasets were small single-cell PBMC cohorts (<10,000 cells total) used for single-cell integration demonstrations; TCRMatch additionally evaluated an independent 10x dataset of 15,769 CDR3Ξ² sequences.
AlphaFold3 achieved median DockQ scores of ~0.636 (class I) and ~0.679 (class II) on the 70-complex TCR-pMHC benchmark β useful to compare methodological performance (structure prediction confidence) against repertoire-scale metrics above.
If you want: I can (A) compute Shannon / Simpson diversity from your uploaded clonotype tables and produce publication-ready multi-panel Plotly figures, or (B) run a deeper meta-analysis across these papers (e.g., diversity vs sequencing depth) using an AI agent.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.